Unconfigured Ad

Collapse
X
 
  • Time
  • Show
Clear All
new posts
  • ymc
    Senior Member
    • Mar 2010
    • 496

    #1

    Coverage, read length and variant calling accuracy

    It seems to me people always think coverage is the more the better. But if such coverage is gained by increasing the read length but with lower quality, can such coverage gain really be converted into better variant calling?

    For example, when you go from HiSeq 2500 rapid mode 2x100 to 2x150, you gained 50% coverage but do you actually have more accurate variant calling?
  • arm55
    Junior Member
    • Feb 2013
    • 3

    #2
    You seem to be confusing coverage and read length. Coverage is the depth of the sequencing, or the average number of reads covering any particular nucleotide.

    When you go from 2x100 to 2x150, you're increasing the read length, not necessarily the coverage. There are advantages to having longer reads (notably, it's easier to detect larger variations), however higher coverage does provide a significant bump in detection power.

    EDIT: Also, with regards to the HiSeq 2500 rapid mode, the advantage is a reduction in time and cost.
    Last edited by arm55; 11-30-2013, 03:54 PM. Reason: More info

    Comment

    • swbarnes2
      Senior Member
      • May 2008
      • 910

      #3
      Unless you are looking for variants in a pool, where you expect the variant to only be a tiny fraction of the overall % of reads covering that position, yeah, I think you are better off with more coverage, even if the base quality is a little lower.

      Comment

      Latest Articles

      Collapse

      • SEQadmin2
        Multiomic Liquid Biopsy: What DNA/RNA Panels Reveal That DNA Alone Can’t
        by SEQadmin2



        Tumors contain complex mixtures of cell populations that evolve in response to treatment and host-specific factors. Tissue biopsies provide only static snapshots of a tumor’s state. But what if we could follow that evolution over time using a minimally invasive technique?

        Liquid biopsies can detect tumor-derived material circulating in the bloodstream, providing a way to study treatment response, detect emerging resistance, and discover new biomarkers. Circulating
        ...
        Today, 09:55 AM
      • SEQadmin2
        New Genomics Technologies Take Aim at Long-Standing Limits
        by SEQadmin2


        Researchers using sequencing and genomics tools often have to make trade-offs. They can choose between speed or scale, short reads or long-range information, or targeted panels or a view of the whole transcriptome. New technologies that have been released this year are built to address those tough choices.

        We asked six companies the same four questions to learn about their latest products. The new technologies bring a lot to the table, including rethinking sequencing
        ...
        09-28-2026, 10:25 AM

      ad_right_rmr

      Collapse

      News

      Collapse

      Topics Statistics Last Post
      Started by SEQadmin2, Today, 05:39 AM
      0 responses
      10 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, Yesterday, 09:56 AM
      0 responses
      11 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 10-09-2026, 11:14 AM
      0 responses
      25 views
      0 reactions
      Last Post SEQadmin2  
      Started by SEQadmin2, 09-29-2026, 09:51 AM
      0 responses
      77 views
      0 reactions
      Last Post SEQadmin2  
      Working...